A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
Clinical trial NCT01358903 · COMPLETED
Trial details
- NCT number
- NCT01358903
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2014-03-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.